All I am seeing is positive signs from analysts. Macquarie has an outperform, UBS and Ord Minnett a buy. Target price is anywhere between $3.80 and $5. EML is by far my largest holding with an average price slightly above $3. I can't see any negative news on its future.
- Forums
- ASX - By Stock
- EML
- 9 out of 10 analysts have an outperform or buy on EML
9 out of 10 analysts have an outperform or buy on EML
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
71.0¢ |
Change
0.050(7.58%) |
Mkt cap ! $268.6M |
Open | High | Low | Value | Volume |
65.5¢ | 72.0¢ | 65.5¢ | $1.088M | 1.537M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14070 | 70.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
71.5¢ | 5352 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14070 | 0.700 |
2 | 17526 | 0.695 |
7 | 52253 | 0.690 |
2 | 25352 | 0.685 |
2 | 7941 | 0.680 |
Price($) | Vol. | No. |
---|---|---|
0.715 | 5352 | 1 |
0.720 | 112819 | 6 |
0.725 | 38072 | 4 |
0.730 | 109543 | 4 |
0.735 | 13417 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online